1
TITLE: Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial  Full Text
AUTHORS: Joel Charrow; Cristina Fraga; Xuefan F Gu; Hiroyuki Ida; Nicola Longo; Elena Lukina; Alexandre Nonino; Sebastiaan J M Gaemers; Marie Helene Jouvin; Jing Li; Yaoshi S Wu; Yong Xue; Judith J Peterschmitt;
PUBLISHED: 2018, SOURCE: MOLECULAR GENETICS AND METABOLISM, VOLUME: 123, ISSUE: 3
INDEXED IN: WOS